DRTECH Corp.

As of June 30, 2026, DRTECH Corp. carries a market capitalization of 428.24B, placing it among publicly traded companies globally. Its enterprise value stands at 481.33B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

DRTECH Corp.'s next confirmed earnings release is scheduled for November 12, 2026.

As of June 30, 2026, DRTECH Corp. has 83.48M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 2.62, and the price-to-book ratio stands at 5.08.

As of June 30, 2026, DRTECH Corp. trades at an EV/EBITDA multiple of 388.19 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 3.81 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 481.33B versus a market cap of 428.24B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, DRTECH Corp. maintains a current ratio of 1.94, meaning it holds 1.9x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2026, DRTECH Corp. posted a negative return on equity (ROE) of -16.47, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -5.82, reflecting losses generated across the asset base. The company generates approximately 334.39M in revenue per employee across its workforce of 377.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 1.61 indicates how many times DRTECH Corp. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, DRTECH Corp. recorded an income tax benefit of -1.87B rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -14.40B and -12.53B in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 23, 2026, DRTECH Corp.'s stock has declined approximately 65.90% over the past 52 weeks. The 50-day moving average sits at 4,052.80, while the 200-day moving average is 7,468.83.

Over the twelve months ended June 30, 2026, DRTECH Corp. generated 126.23B in revenue and converted that into -12.53B in net income, yielding earnings per share of -179.98. EBITDA reached 1.24B, while operating income came in at -10.03B.

As of June 30, 2026, DRTECH Corp. holds 48.50B in cash and equivalents against 101.06B in total debt, resulting in a net debt position of 43.98B. Total book value stands at 84.29B, with working capital of 84.82B providing operational flexibility.

DRTECH Corp. produced -8.68B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -5.68B in capital expenditures, free cash flow totaled -14.35B - equivalent to -222.61 per share.

Over the twelve months ended June 30, 2026, DRTECH Corp. posted a gross margin of 39.65, reflecting its pricing power and cost economics. The operating margin of -7.94 and net profit margin of -9.93 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -4.02: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -8.53, meaning DRTECH Corp. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

DRTECH Corp.'s most recent stock split took place on September 10, 2026 with a 5:1 split ratio.

As of June 30, 2026, DRTECH Corp. has an Altman Z-Score of 2.28, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.